Delcath Systems to Participate in Upcoming Investor Conferences

On July 30, 2024 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that management will be attending the following upcoming investor conferences (Press release, Delcath Systems, JUL 30, 2024, View Source [SID1234645153]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Virtual Biotechnology Conference
Date: Tuesday, August 6, 2024
Location: Virtual

Canaccord Genuity’s 44th Annual Growth Conference
Date: Wednesday, August 14, 2024
Presentation Time: 9:30 am Eastern Time
Location: Boston, MA